TENAX THERAPEUTICS, INC. (TENX) Current Ratio
- Current ratio · latest quarter: Value 15.07×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 15.07× | Current assets / current liabilities. $121.66M ÷ $8.07M ≈ 15.07× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 121.66M USD | Assets, Current |
| Current obligations | 8.07M USD | Liabilities, Current |
| Cash and equivalents | 118.00M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Marketable Securities, Current |
| Customer receivables | (m) | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | (m) | Inventory, Net |
| Payables | 6.79M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $121.66M | $8.07M | $118.00M | (m) | (m) | (m) | $6.79M | (m) | 15.07× |
| 2026-03-31 | $123.18M | $8.49M | $118.80M | (m) | (m) | (m) | $6.35M | (m) | 14.52× |
| 2025-12-31 | $104.23M | $7.16M | (m) | (m) | (m) | (m) | $6.04M | (m) | 14.56× |
| 2025-09-30 | $102.81M | $6.60M | $99.40M | (m) | (m) | (m) | $5.61M | (m) | 15.58× |
| 2025-06-30 | $105.86M | $2.53M | $105.50M | (m) | (m) | (m) | $562.00K | (m) | 41.89× |
| 2025-03-31 | $112.06M | $2.77M | $111.40M | (m) | (m) | (m) | $1.84M | (m) | 40.48× |
| 2024-12-31 | $96.69M | $4.69M | $94.90M | (m) | (m) | (m) | $3.16M | (m) | 20.60× |
| 2024-09-30 | $99.78M | $2.56M | (m) | (m) | (m) | (m) | $1.58M | (m) | 38.95× |
| 2024-06-30 | $10.62M | $1.74M | (m) | (m) | (m) | (m) | $869.66K | (m) | 6.10× |
| 2024-03-31 | $14.46M | $2.03M | (m) | (m) | (m) | (m) | $1.08M | (m) | 7.12× |
| 2023-12-31 | $11.68M | $3.59M | $9.80M | (m) | (m) | (m) | $2.07M | (m) | 3.26× |
| 2023-09-30 | $11.88M | $602.21K | (m) | (m) | (m) | (m) | $134.79K | (m) | 19.73× |
| 2023-06-30 | $14.04M | $823.84K | $13.39M | (m) | (m) | (m) | $206.46K | (m) | 17.04× |
| 2023-03-31 | $15.26M | $983.86K | $14.41M | (m) | (m) | (m) | $172.03K | (m) | 15.52× |
| 2022-12-31 | $3.21M | $1.85M | (m) | (m) | (m) | (m) | $448.43K | (m) | 1.74× |
| 2022-09-30 | $4.51M | $689.82K | $3.81M | (m) | (m) | (m) | $265.41K | (m) | 6.54× |
| 2022-06-30 | $8.10M | $1.45M | $7.23M | (m) | (m) | (m) | $919.38K | (m) | 5.60× |
| 2022-03-31 | $3.46M | $1.98M | $2.87M | (m) | (m) | (m) | $1.29M | (m) | 1.75× |
| 2021-12-31 | $5.69M | $1.56M | $5.58M | (m) | (m) | (m) | $859.64K | (m) | 3.64× |
| 2021-09-30 | $8.58M | $1.46M | $8.35M | $0.00 | (m) | (m) | $776.25K | (m) | 5.87× |
| 2021-06-30 | $2.53M | $1.18M | $1.67M | $510.94K | (m) | (m) | $791.95K | (m) | 2.16× |
| 2021-03-31 | $4.52M | $1.43M | $3.54M | $494.88K | (m) | (m) | $997.44K | (m) | 3.15× |
| 2020-12-31 | $6.80M | $2.12M | $6.25M | $462.69K | (m) | (m) | $757.86K | (m) | 3.21× |
| 2020-09-30 | $8.90M | $1.38M | $8.24M | $472.65K | (m) | (m) | $1.05M | (m) | 6.45× |
| 2020-06-30 | $5.21M | $2.19M | $4.09M | $468.22K | (m) | (m) | $1.56M | (m) | 2.38× |
| 2020-03-31 | $5.80M | $2.51M | $4.36M | $498.54K | (m) | (m) | $1.81M | (m) | 2.31× |
| 2019-12-31 | $6.18M | $2.53M | $4.91M | $493.88K | (m) | (m) | $1.66M | (m) | 2.44× |
| 2019-09-30 | $7.56M | $1.13M | $6.65M | $478.54K | (m) | (m) | $225.52K | (m) | 6.70× |
| 2019-06-30 | $9.42M | $938.09K | $8.41M | $502.13K | (m) | (m) | $448.82K | (m) | 10.05× |
| 2019-03-31 | $11.19M | $1.01M | $10.32M | $501.63K | (m) | (m) | $596.81K | (m) | 11.03× |
| 2018-12-31 | $13.32M | $1.57M | $12.37M | $494.63K | (m) | (m) | $749.81K | (m) | 8.51× |
| 2018-09-30 | $5.14M | $516.16K | $3.35M | $1.51M | $0.00 | (m) | $392.48K | (m) | 9.96× |
| 2018-06-30 | $6.71M | $792.79K | $3.90M | $2.50M | $39.29K | (m) | $203.15K | (m) | 8.46× |
| 2018-03-31 | $6.99M | $311.04K | $2.99M | $3.62M | $39.29K | (m) | $189.56K | (m) | 22.48× |
| 2017-12-31 | $8.06M | $1.01M | $1.60M | $6.12M | $50.17K | (m) | $611.86K | (m) | 7.99× |
| 2017-09-30 | $8.66M | $838.55K | $1.76M | $6.77M | $24.65K | (m) | $579.39K | (m) | 10.33× |
| 2017-06-30 | $9.00M | $2.18M | $2.23M | $6.56M | $24.65K | (m) | $434.19K | (m) | 4.12× |
| 2017-03-31 | $12.79M | $5.04M | $7.03M | $5.50M | $24.65K | (m) | $1.40M | (m) | 2.54× |
| 2016-12-31 | $13.63M | $6.20M | $10.00M | $3.28M | $72.60K | (m) | $727.60K | (m) | 2.20× |
| 2016-09-30 | $7.67M | $5.06M | $722.15K | $6.76M | $72.60K | (m) | $1.39M | (m) | 1.52× |
| 2016-06-30 | $10.18M | $5.28M | $1.93M | $8.02M | $24.65K | (m) | $1.52M | (m) | 1.93× |
| 2016-03-31 | $16.10M | $6.24M | $3.26M | $12.51M | $49.30K | (m) | $2.12M | (m) | 2.58× |
| 2015-12-31 | $20.56M | $4.60M | $3.66M | $16.53M | $49.45K | (m) | $972.48K | (m) | 4.47× |
| 2015-10-31 | $21.86M | $3.56M | $5.10M | $16.58M | $86.27K | (m) | $521.23K | (m) | 6.14× |
| 2015-07-31 | $21.60M | $3.25M | $3.65M | $17.66M | $98.59K | (m) | $680.69K | (m) | 6.64× |
| 2015-04-30 | $17.51M | $4.52M | $7.93M | $9.20M | $76.47K | (m) | $1.18M | (m) | 3.88× |
| 2015-01-31 | $17.67M | $2.87M | $9.92M | $7.16M | $64.66K | (m) | $425.23K | (m) | 6.16× |
| 2014-10-31 | $23.01M | $3.67M | $14.36M | $8.23M | $36.36K | (m) | $1.65M | (m) | 6.26× |
| 2014-07-31 | $26.66M | $1.90M | $21.96M | $4.17M | $36.36K | (m) | $585.91K | (m) | 14.06× |
| 2014-04-30 | $58.97M | $2.57M | $58.32M | (m) | $36.36K | (m) | $411.14K | (m) | 22.93× |
| 2014-01-31 | $7.39M | $3.61M | $6.34M | (m) | $53.11K | $97.44K | $668.67K | (m) | 2.04× |
| 2013-10-31 | $3.09M | $1.48M | $2.54M | (m) | $64.81K | $97.98K | $920.84K | (m) | 2.10× |
| 2013-07-31 | $4.59M | $4.71M | $4.07M | (m) | $96.79K | $98.94K | $969.57K | (m) | 0.97× |
| 2013-04-30 | $1.84M | $1.91M | $783.53K | (m) | $445.24K | $99.20K | $977.16K | (m) | 0.96× |
| 2013-01-31 | $1.65M | $1.99M | $828.81K | (m) | $13.64K | $107.94K | $807.68K | (m) | 0.83× |
| 2012-10-31 | $2.12M | $1.35M | $1.51M | (m) | $17.19K | $109.36K | $479.30K | (m) | 1.57× |
| 2012-07-31 | $3.65M | $4.00M | $2.69M | (m) | $23.63K | $114.14K | $835.10K | (m) | 0.91× |
| 2012-04-30 | $2.63M | $3.13M | $1.88M | (m) | $13.38K | $83.37K | $542.81K | (m) | 0.84× |
| 2012-01-31 | $4.33M | $5.81M | $3.28M | (m) | $19.40K | $116.71K | $650.35K | (m) | 0.75× |
| 2011-10-31 | $2.87M | $2.10M | $2.00M | (m) | $7.56K | $95.72K | $781.51K | (m) | 1.37× |
| 2011-07-31 | $4.50M | $2.27M | $4.00M | (m) | $28.12K | $205.49K | $1.06M | (m) | 1.99× |
| 2011-04-30 | $1.63M | $2.18M | $951.94K | (m) | $138.87K | $257.38K | $889.38K | (m) | 0.75× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |